Title
Serum albumin, NLR and PLR in pre-treatment assessment of bronchiectasis exacerbations
Authors
G. Reetu* & Vinod Kumar Viswanathan
Affiliation
Department of Respiratory Medicine, Institute of Thoracic Medicine, Madras Medical College, the Tamilnadu Dr. MGR Medical University, Chennai, Tamilnadu, India; *Corresponding author
G. Reetu - E-mail: drreetu.email@gmail.com
Vinod Kumar Viswanathan - E-mail: drvinodkumar76@gmail.com
Article Type
Research Article
Date
Received June 1, 2026; Revised June 30, 2026; Accepted June 30, 2026, Published June 30, 2026
Abstract
Bronchiectasis severity scores, through useful in disease progression, are inadequate for monitoring exacerbation treatment. Therefore, it is of interest to investigate the correlation between serum albumin, Platelet Lymphocyte Ratio (PLR) and Neutrophil Lymphocyte Ratio (NLR) with disease severity in exacerbated bronchiectasis patients. Serum albumin and NLR demonstrated significant correlation with disease severity, while PLR did not. Post-treatment, both markers showed improvement, indicating their role in treatment monitoring. Thus, we show NLR and serum albumin as reliable biomarkers for assessing severity and monitoring treatment response in bronchiectasis.
Keywords
Albumin, bronchiectasis, neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), severity
Citation
Reetu & Viswanathan et al. Bioinformation 22(6): 3236-3239 (2026)
Edited by
Ritik Kashwani
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
